Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

Autor: Rasmussen BB (AUTHOR), Regan MM (AUTHOR), Lykkesfeldt AE (AUTHOR), Dell'Orto P (AUTHOR), Del Curto B (AUTHOR), Henriksen KL (AUTHOR), Mastropasqua MG (AUTHOR), Price KN (AUTHOR), Méry E (AUTHOR), Lacroix-Triki M (AUTHOR), Braye S (AUTHOR), Altermatt HJ (AUTHOR), Gelber RD (AUTHOR), Castiglione-Gertsch M (AUTHOR), Goldhirsch A (AUTHOR), Gusterson BA (AUTHOR), Thürlimann B (AUTHOR), Coates AS (AUTHOR), Viale G (AUTHOR), BIG 1-98 Collaborative and International Breast Cancer Study Groups (CORPORATE AUTHOR)

Publikováno v: Lancet Oncology. Jan2008, Vol. 9 Issue 1, p23-28. 6p.

Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy.

Autor: Larsen MS; Department of Pathology, Herlev Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark. mathilde.skaarup.larsen@regionh.dk, Bjerre K, Lykkesfeldt AE, Giobbie-Hurder A, Laenkholm AV, Henriksen KL, Ejlertsen B, Rasmussen BB

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2012 Oct; Vol. 21 (5), pp. 662-8. Date of Electronic Publication: 2012 Jul 31.

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.

Autor: Ejlertsen B; Danish Breast Cancer Cooperative Group Statistical Center; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: ejlertsen@rh.dk., Aldridge J; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA., Nielsen KV; Dako A/S, Glostrup, Denmark., Regan MM; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA; Department of Biostatistics, Harvard School of Public Health; Department of Medicine, Harvard Medical School, Boston, USA., Henriksen KL; Department of Breast Cancer Research, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark., Lykkesfeldt AE; Department of Breast Cancer Research, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark., Müller S; Dako A/S, Glostrup, Denmark., Gelber RD; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA; Department of Biostatistics, Harvard School of Public Health; Department of Medicine, Harvard Medical School, Boston, USA; International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, USA., Price KN; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA; International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, USA., Rasmussen BB; Department of Pathology, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark., Viale G; Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Pathology Review Office, European Institute of Oncology, University of Milan, Milan, Italy., Mouridsen H; Danish Breast Cancer Cooperative Group Statistical Center; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2012 May; Vol. 23 (5), pp. 1138-1144. Date of Electronic Publication: 2011 Oct 10.

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.

Autor: Lykkesfeldt AE; Department of Tumor Endocrinology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen Ø, Denmark. al@cancer.dk, Henriksen KL, Rasmussen BB, Sasano H, Evans DB, Møller S, Ejlertsen B, Mouridsen HT

Publikováno v: BMC cancer [BMC Cancer] 2009 Jun 16; Vol. 9, pp. 185. Date of Electronic Publication: 2009 Jun 16.